International Journal of Rheumatic Diseases
© Asia Pacific League of Associations for Rheumatology and Wiley Publishing Asia Pty Ltd
Edited By: Debashish Danda
Impact Factor: 1.469
ISI Journal Citation Reports © Ranking: 2014: 23/32 (Rheumatology)
Online ISSN: 1756-185X
NIH Public Access Mandate
For those interested in the Wiley policy on the NIH Public Access Mandate, please visit our policy statement
Thank you for your interest in International Journal of Rheumatic Diseases. Please read the complete Author Guidelines carefully prior to submission, including the section on copyright. To ensure fast peer review and publication, manuscripts that do not adhere to the following instructions will be returned to the corresponding author for technical revision before undergoing peer review.
Note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium. Once you have prepared your submission in accordance with the Guidelines, manuscripts should be submitted online at mc.manuscriptcentral.com/aplar
If you are currently a reviewer for our journal please email email@example.com for your Login ID and Password. If you are new to the journal please create an author account for yourself by clicking the link on the top right hand corner of the webpage. After logging in you will be able to submit your paper by following the steps. When uploading your manuscript please note that all figures should be uploaded in separate eps or tiff files (See Figures section below). Please email firstname.lastname@example.org if you have any difficulties.
We look forward to your submission.
Manuscripts should be written so that they are intelligible to the professional reader who is not a specialist in the particular field. Where contributions are judged as acceptable for publication on the basis of scientific content, the Editor or the Publisher reserves the right to modify typescripts to eliminate ambiguity and repetition and improve communication between author and reader.
The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are peer reviewed by two anonymous reviewers and the Editor. The Editorial Board reserves the right to refuse any material for publication. Final acceptance or rejection rests with the Editorial Board.
Prior to the submission of a manuscript, authors should familiarize themselves and comply with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals relating to:
Conflict of interest
Protection of patients’ rights to privacy
Redundant or duplicate publication
Sponsorship, authorship and accountability
Authors must confirm that they have followed the appropriate ethics protocol. Statements confirming this must be included within the Methods of their manuscript. These include:
• That the protocol for the research project has been approved by a suitably constituted Ethics Committee of the institution within which the work was undertaken and have therefore been performed in accordance with the ethical standards laid down in an appropriate version of the Declaration of Helsinki (as revised in Brazil 2013), available at http://www.wma.net/en/30publications/10policies/b3/index.html.
• All persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identity of the subjects under the study should be omitted.
• Reports of animal experiments must state that the ‘Principles of Laboratory Animal Care’ (NIH Publication Vol 25, No. 28 revised 1996; http://grants.nih.gov/grants/guide/notice-files/not96-208.html) were followed, as well as specific national laws (e.g. the current version of the German Law on the Protection of Animals) where applicable.
SPECIFICS FOR MANUSCRIPT SUBMISSION BY ARTICLE TYPE
Editorials usually provide commentary on an article in the issue of the Journal. Editorials are commissioned by the Editor-in-Chief, though unsolicited editorials may be considered.
Reviews are comprehensive analyses of specific topics either basic or clinical. They are submitted upon invitation by the Editors. Proposals for reviews may be submitted; however, in this case authors should only send an outline of the proposed paper for initial consideration. Both solicited and unsolicited review articles will undergo peer review prior to acceptance. They should contain a maximum of 4000 words (excluding Abstract, Tables, and References).
Original Articles should reflect original work that embodies scientific excellence in rheumatology and advances in clinical research. They should contain a maximum of 4000 words (excluding Abstract, Tables, and References) and must contain a structured Abstract of 250 words or less together with a list of key words and up to 6 tables or figures and a maximum of 50 references. Divide the Abstract with the headings: Aim, Method, Results, Conclusion.
Novel Hypothesis offers the researchers an opportunity to raise aclinical or experimentalhypothesis,which is based on Biological basis, but yet to be proven. The text is limited to a maximum of 1,000 words including abstract but excluding references, tables and figures. No abstract is required.
APLAR Grand Round Case
APLAR Grand Round Case an exceptional case with novel message and in depth work up and educative discussion, the text is limited to 1500 words.
Postgraduate Quiz can include a number of images of rare, classical or interesting case, each image should be accompanied by a brief summary of the case (if appropriate) and question(s) that are designed to test the participant's knowledge. The answer(s) should follow separately and should include a brief description of the diagnostic features of the image and the key learning points. The text is limited to 1000 words.
Rheumatology News & Views from APLAR Region
They can be political, social, economic, cultural and other regional issues and comments relevant to the Rheumatology in the APLAR region
Expert Comments on Recent Publications
Expert Comments on Recent Publications are solicited by the Editor-in-Chief. Top expert(s) will be invited to summarise top 10 publications within the recent past 2 months with relevant learning points. The text is limited to 1500 words.
Correspondences discuss a recent article published in the International Journal of Rheumatic Diseases(IJRD). Correspondences being considered for publication will be sent to the authors of the IJRD article, who will be given the opportunity to reply. Interesting case reports may be published under this category. They should be no more than 1000 words with a maximum of 10 references and up to 2 figures or tables. No Abstract or key words are required.
Milestones in Science, Art and Commerce of Rheumatology
This column reviews the landmark developments of rheumatology, including write up about a great scientist in Rheumatology or exemplary patients. The text is limited to 1500 words.
Letter from the Editor
Letter from the Editor are the Editor’s opinion on any issue relevant to the journal. It may be merged with the Editorial.
GENERAL INFORMATION FOR AUTHORS FOR ALL ARTICLE TYPES
•Manuscripts should follow the style of the Vancouver agreement detailed in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, as presented in JAMA 1997; 277: 927–34.
• The journal uses US spelling and authors should therefore follow the latest edition of Merriam–Webster’s Collegiate Dictionary.
• All measurements must be given in SI units as outlined in the latest edition of Units, Symbols and Abbreviations: A Guide for Medical and Scientific Editors and Authors (Royal Society of Medicine Press, London).
• Abbreviations should be used sparingly and only where they ease the reader’s task by reducing repetition of long, technical terms. Initially use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation.
• Drugs should be referred to by their generic names, rather than brand names.
Parts of the Manuscript
The manuscript should be submitted in separate files: title page; main text file; figures.
The title page should contain:
(i) A short informative title that contains the major key words. The title should not contain abbreviations
(ii) The full names of the authors
(iii) The author's institutional affiliations at which the work was carried out
(iv) In keeping with the latest guidelines of the International Committee of Medical Journal Editors, each author’s contribution to the paper is to be quantified
(v) A short running title (less than 40 characters, including spaces)
(iv) the full postal and email address, plus telephone number, of the author to whom correspondence about the manuscript should be sent
The present address of any author, if different from that where the work was carried out, should be supplied in a footnote.
Acknowledgments The source of financial grants and other funding should be acknowledged, including a frank declaration of the authors’ industrial links and affiliations. The contribution of colleagues or institutions should also be acknowledged. Thanks to anonymous reviewers are not allowed.
As papers are double-blind peer reviewed the main text file should not include any information that might identify the authors. The main text of the manuscript should be presented in the following order unless otherwise specified in the section 'Specifics for Manuscript Submission by Article Type'.
(i) abstract and key words, (ii) text, (iii) references, (iv) tables (each table complete with title and footnotes), and (v) figure legends. Figures should be submitted as separate files.
The Vancouver system of referencing should be used. In the text, references should be cited using superscript Arabic numerals in the order in which they appear. If cited only in tables or figure legends, number them according to the first identification of the table or figure in the text. In the reference list, the references should be numbered and listed in order of appearance in the text. Cite the names of all authors when there are six or less; when seven or more list the first three followed by et al. Names of journals should be abbreviated in the style used in Index Medicus. Reference to unpublished data and personal communications should appear in the text only.
References should be listed in the following form.
Journal article: Needleman P, Isakson PC (1997) The discovery and function of COX-2. J Rheumatol 24,6–7.
Book: Munthe E (ed.) The Care of Rheumatic Children. European League Against Rheumatism, Basel, Switzerland.
Chapter in a book: Croft P (1993) Soft tissue rheumatism. In: AJ Silman, MC Hochberg (eds) Epidemiology of the Rheumatic Diseases, pp. 375–421. Oxford University Press, Oxford.
Tables should be self-contained and complement, but not duplicate, information contained in the text. Tables should be numbered consecutively in Arabic numerals. Each table should be presented on a separate page with a comprehensive but concise legend above the table. Tables should be double-spaced and vertical lines should not be used to separate columns. Column headings should be brief, with units of measurement in parentheses; all abbreviations should be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. The table and its legend/footnotes should be understandable without reference to the text.
Type figure legends on a separate page. Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.
All illustrations (line drawings and photographs) are classified as figures. Figures should be numbered using Arabic numerals, and cited in consecutive order in the text. Each figure should be supplied as a separate file, with the figure number incorporated in the file name.
Preparation of Electronic Figures for Publication: Although low quality images are adequate for review purposes, publication requires high quality images to prevent the final product being blurred or fuzzy. Advice on figures can be found at Wiley’s guidelines for preparation of figures: http://authorservices.wiley.com/bauthor/illustration.asp
• A cover letter should be included in the ‘Cover Letter Field’ of the ScholarOne system. The text can be entered directly into the field or uploaded as a file.
• The cover letter must include: (i) a statement confirming that the content of this submission has not been published or submitted for publication elsewhere, (ii) an acknowledgment that all authors have contributed significantly and are in agreement with the content of the manuscript, (iii) a statement confirming that the protocol for the research project has been approved by a suitably constituted Ethics Committee of the institution within which the work was undertaken and that it conforms to the provisions of the Declaration of Helsinki (as revised in Brazil 2013), available at http://www.wma.net/en/30publications/10policies/b3/index.html, (iv) a declaration of any financial support or relationships that may pose conflict of interest.
• Authors must declare any financial support or relationships that may pose conflict of interest in the ‘Conflict of Interest’ field in the ScholarOne System.
• Two Word-files need to be included upon submission: A title page file and a main text file that includes all parts of the text in the sequence indicated in the section 'Parts of the manuscript', including tables and figure legends but excluding figures which should be supplied separately.
• The main text file should be prepared using Microsoft Word, doubled-spaced. The top, bottom and side margins should be 30 mm. New paragraphs should be indented.
• Each figure should be supplied as a separate file, with the figure number incorporated in the file name. For submission, low-resolution figures saved as .jpg or .bmp files should be uploaded, for ease of transmission during the review process. Upon acceptance of the article, high-resolution figures (at least 300 d.p.i.) saved as .eps or .tif files will be required.
PUBLICATION PROCESS AFTER ACCEPTANCE
Accepted papers will be passed to Wiley’s production team for publication. The author identified as the formal corresponding author for the paper will receive an email prompting them to login into Wiley’s Author Services, where via the Wiley Author Licensing Service (WALS) they will be asked to complete an electronic license agreement on behalf of all authors on the paper. More details on the copyright and licencing options for the journal appear below.
Wiley’s Author Services
Author Services enables authors to track their article through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated e-mails at key stages of production. The corresponding author will receive a unique link that enables them to register and have their article automatically added to the system. Please ensure that a complete e-mail address is provided when submitting the manuscript. Visit http://www.authorservices.wiley.com/ for more details on online production tracking and for a wealth of resources including FAQs and tips on article preparation, submission and more.
Once the paper has been typeset the corresponding author will receive an e-mail alert containing instructions on how to provide proof corrections to the article. It is therefore essential that a working e-mail address is provided for the corresponding author. Proofs should be corrected carefully; the responsibility for detecting errors lies with the author.
The journal offers rapid speed to publication via Wiley’s Early View service. Early View articles are complete full-text articles published online in advance of their publication in a printed issue. Early View articles are complete and final. They have been fully reviewed, revised and edited for publication, and the authors' final corrections have been incorporated. Because they are in final form, no changes can be made after online publication. Early View articles are given a Digital Object Identifier (DOI), which allows the article to be cited and tracked before allocation to an issue. After print publication, the DOI remains valid and can continue to be used to cite and access the article. More information about DOIs can be found at http://www.doi.org/faq.html.
A PDF reprint of the article will be supplied free of charge to the corresponding author. Additional printed offprints may be ordered online for a fee. Please click on the following link and fill in the necessary details and ensure that you type information in all of the required fields: http://offprint.cosprinters.com/cos. If you have queries about offprints please e-mail: email@example.com.
Author Marketing Toolkit
The Wiley Author Marketing Toolkit provide authors with support on how to use social media, publicity, conferences, multimedia, email and the web to promote their article.
COPYRIGHT, LICENSING AND ONLINE OPEN
Accepted papers will be passed to Wiley’s production team for publication. The author identified as the formal corresponding author for the paper will receive an email prompting them to login into Wiley’s Author Services, where via the Wiley Author Licensing Service (WALS) they will be asked to complete an electronic license agreement on behalf of all authors on the paper.
Authors may choose to publish under the terms of the journal’s standard copyright transfer agreement (CTA), or under open access terms made available via Wiley OnlineOpen.
Standard Copyright Transfer Agreement: FAQs about the terms and conditions of the standard CTA in place for the journal, including standard terms regarding archiving of the accepted version of the paper, are available at: Copyright Terms and Conditions FAQs.
Note that in signing the journal’s licence agreement authors agree that consent to reproduce figures from another source has been obtained.
OnlineOpen – Wiley’s Open Access Option: OnlineOpen is available to authors of articles who wish to make their article freely available to all on Wiley Online Library under a Creative Commons license. With OnlineOpen, the author, the author's funding agency, or the author's institution pays a fee to ensure that the article is made open access. Authors of OnlineOpen articles are permitted to post the final, published PDF of their article on their personal website, and in an institutional repository or other free public server immediately after publication. All OnlineOpen articles are treated in the same way as any other article. They go through the journal's standard peer-review process and will be accepted or rejected based on their own merit.
OnlineOpen licenses. Authors choosing OnlineOpen retain copyright in their article and have a choice of publishing under the following Creative Commons License terms: Creative Commons Attribution License (CC BY); Creative Commons Attribution Non-Commercial License (CC BY NC); Creative Commons Attribution Non-Commercial-NoDerivs License (CC BY NC ND). To preview the terms and conditions of these open access agreements please visit the Copyright Terms and Conditions FAQs.
Funder Open Access and Self-Archiving Compliance: Please click here for more information on Wiley’s compliance with specific Funder Open Access and Self Archiving Policies, and click here for more detailed information specifically about Self-Archiving definitions and policies.
Author Guidelines updated 3 June 2015